Abstract
A visionary report released by the Lancet Commission on Investing in Health–Global Health 2035–asserts that we can accomplish significant health gains in low- and middle-income countries by 2035–to achieve a grand convergence. Aligned with Global Health 2035, a new Global Investment Framework for Women’s and Children’s Health (the Framework) maps the health, economic, and social gains that result from a greater investment in women’s and children’s health during the same time period. Family planning commodity costs and the associated supply chain operational costs required to minimize the unmet need for family planning are important elements of the overall Framework costs.
